China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. - B (02509.HK) intends to acquire approximately 34.0001% equity of Saifushi.

Zhijing Finance and Economics APP news, Chuen Sen Biotechnology-B (02509.HK) announced that on June 26, 2026, Saifoo Energy (a wholly-owned subsidiary of the company) entered into a share transfer agreement with Taizhou Huacheng. Saifoo Energy conditionally agreed to acquire, while Taizhou Huacheng conditionally agreed to sell the target shares (approximately 34.0001% of the shares of Saifoo) for a price of 86.02 million yuan. The share transfer will be implemented on the day when the relevant authorities complete the share change registration (Saifoo Energy must be completed within 30 business days after paying the price in full and signing the share transfer agreement).